These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35972038)

  • 1. Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care.
    Rosenstengle C; Kripalani S; Rahimi RS
    J Hosp Med; 2022 Aug; 17 Suppl 1():S17-S23. PubMed ID: 35972038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.
    Seraj SM; Campbell EJ; Argyropoulos SK; Wegermann K; Chung RT; Richter JM
    World J Gastroenterol; 2017 Oct; 23(37):6868-6876. PubMed ID: 29085229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study.
    Tapper EB; Halbert B; Mellinger J
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1181-1188.e2. PubMed ID: 27085758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge.
    Okafor PN; Nnadi AK; Okoli O; Huang AE; Nwaiwu O
    Am J Gastroenterol; 2019 Mar; 114(3):464-471. PubMed ID: 30676364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital readmissions among patients with decompensated cirrhosis.
    Volk ML; Tocco RS; Bazick J; Rakoski MO; Lok AS
    Am J Gastroenterol; 2012 Feb; 107(2):247-52. PubMed ID: 21931378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Management: Modern Measures to Prevent Readmission in Patients with Hepatic Encephalopathy.
    Rosenblatt R; Yeh J; Gaglio PJ
    Clin Liver Dis; 2020 May; 24(2):277-290. PubMed ID: 32245533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.
    Tapper EB; Aberasturi D; Zhao Z; Hsu CY; Parikh ND
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1397-1405. PubMed ID: 32363684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
    Hu XP; Gao J
    World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.
    Khan A; Maheshwari S; Gupta K; Naseem K; Chowdry M; Singh S
    J Gastroenterol Hepatol; 2021 Mar; 36(3):775-781. PubMed ID: 32710679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy.
    Vadhariya A; Chen H; Serna O; Zamil H; Abughosh SM
    Medicine (Baltimore); 2020 Apr; 99(16):e19603. PubMed ID: 32311928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Wei M; Ford J; Li Q; Jeong D; Kwong AJ; Nguyen MH; Chang MS
    Dig Dis Sci; 2018 Sep; 63(9):2267-2274. PubMed ID: 29457210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.
    Shaheen AA; Nguyen HH; Congly SE; Kaplan GG; Swain MG
    Liver Int; 2019 May; 39(5):878-884. PubMed ID: 30688401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional Assessment in Inpatients With Cirrhosis Can Be Improved After Training and Is Associated With Lower Readmissions.
    Reuter B; Shaw J; Hanson J; Tate V; Acharya C; Bajaj JS
    Liver Transpl; 2019 Dec; 25(12):1790-1799. PubMed ID: 31301208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis.
    Tapper EB; Volk M
    Curr Gastroenterol Rep; 2017 Jan; 19(1):1. PubMed ID: 28101791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis.
    Tapper EB; Finkelstein D; Mittleman MA; Piatkowski G; Chang M; Lai M
    Clin Gastroenterol Hepatol; 2016 May; 14(5):753-9. PubMed ID: 26407750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
    Xu XY; Ding HG; Li WG; Jia JD; Wei L; Duan ZP; Liu YL; Ling-Hu EQ; Zhuang H; Hepatology CSO; Association CM
    World J Gastroenterol; 2019 Sep; 25(36):5403-5422. PubMed ID: 31576089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Hirode G; Vittinghoff E; Wong RJ
    Dig Dis Sci; 2019 Jun; 64(6):1448-1457. PubMed ID: 30863953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Frenette CT; Levy C; Saab S
    Dig Dis Sci; 2022 Jun; 67(6):1994-2004. PubMed ID: 34169435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient management of cirrhosis: a narrative review.
    Mathews RE; McGuire BM; Estrada CA
    South Med J; 2006 Jun; 99(6):600-6. PubMed ID: 16800415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.